DRUGABILIS

Drugabilis is a fully independent, privately owned, drugability-focused drug discovery and preclinical-development company located in the southwest of Paris, France. It is the first CRO specialized in pharmaceutical physicochemical characterization and formulation as applied to the early selection of new drug candidates. It delivers both experimental support and consulting services to its customer’s research efforts by supporting the selection of drugable compounds and delivery systems.